Discovery of Potent, Orally Bioavailable, Small-Molecule Inhibitors of WNT Signaling from a Cell-Based Pathway Screen

Author:

Mallinger Aurélie1,Crumpler Simon1,Pichowicz Mark1,Waalboer Dennis1,Stubbs Mark1,Adeniji-Popoola Olajumoke1,Wood Bozena2,Smith Elizabeth1,Thai Ching1,Henley Alan T.1,Georgi Katrin3,Court William1,Hobbs Steve1,Box Gary1,Ortiz-Ruiz Maria-Jesus1,Valenti Melanie1,De Haven Brandon Alexis1,TePoele Robert1,Leuthner Birgitta3,Workman Paul1,Aherne Wynne1,Poeschke Oliver3,Dale Trevor2,Wienke Dirk3,Esdar Christina3,Rohdich Felix3,Raynaud Florence1,Clarke Paul A.1,Eccles Suzanne A.1,Stieber Frank3,Schiemann Kai3,Blagg Julian1

Affiliation:

1. Cancer Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London SW7 3RP, U.K.

2. School of Bioscience, Cardiff University, Cardiff CF10 3XQ, U.K.

3. Merck KGaA, Merck Serono, 64293 Darmstadt, Germany

Funder

Cancer Research UK

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3